• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.08% Nasdaq Down 0.35%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    0.84 Up 0.05(5.68%) Feb 9, 4:02PM EST
    |After Hours : 0.84 0.00 (0.00%) Feb 9, 4:18PM EST
    Prev Close:0.80
    Open:0.79
    Bid:0.84 x 500
    Ask:0.85 x 2300
    1y Target Est:1.83
    Beta:-0.039017
    Earnings Date:Mar 3 - Mar 7 (Est.)
    Day's Range:0.78 - 0.87
    52wk Range:0.75 - 2.50
    Volume:266,858
    Avg Vol (3m):499,142
    Market Cap:131.30M
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBUp 5.68%131.30M
    LLYDown 0.61%78.09B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.75
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.19
    Quarterly EPS Est (Dec-15) :-0.04
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a precision medicine company, focuses on the development and commercialization of precision diagnostics, therapeutics, and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback